Tuesday, January 14, 2014

VIDEO: The Death Cycle of Health Insurance

This is the best explanation I have come across that gets to the core of Obamacare and what is wrong with it.

2 comments:

  1. the fda stands in the way of competition and thwarts innovation...who wouldn't want to take a therapy only once....??????????????

    MS patient fights FDA over rejection of Genzyme’s Lemtrada

    A 49-year-old mother from Waterford, Conn., has become an ally of Cambridge, Mass.-based drug giant Genzyme in its efforts to get U.S. regulators to change their minds about the first-ever once-a-year drug to treat multiple sclerosis.

    Melissa Burdick, who was diagnosed with the degenerative disease 13 years ago, has filed a citizen’s petition requesting that the U.S. Food and Drug Administration approves Lemtrada. The drug was recently been approved in Canada, Australia and Europe, but was denied late last year by the FDA due to a disagreement over the way the drug trials were conducted.
    “I have gone through all the different options,” she said. Lemtrada, on the other hand, is “a brand new way of looking at the disease,” she said. The infused drug essentially eliminates all of the body’s T-cells, and then allows them to replenish themselves, and Burdick said she’s known people who have taken the trug in a trial years ago who have never needed it again.

    Burdick, who works in the business office of a local hospital, attended a meeting last November in which an FDA advisory panel gave contradictory recommendations as to whether the drug should be approved. The disagreement came down to whether the 1,400 patients in the trial should have been told which drug they were taking to avoid bias. The FDA prefers blind trials, but Genzyme argued that there’s no way it could have prevented patients from figuring out whether they were receiving Lemtrada or the drug it was being compared to, EMD Serono’s drug, Rebif.

    “The FDA was just bashing (Genzyme) horribly (at the meeting), because they thought they should have done a blind study,” said Burdick.

    http://www.bizjournals.com/boston/blog/bioflash/2014/01/ms-patient-fights-fda-over-rejection.html?page=all

    plus we would all pay less for health insurance over time.

    ReplyDelete
  2. Yep, the woman plays the uninformed fool, as usual in these Xtranormal videos.

    ReplyDelete